Research analysts at StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a report issued on Sunday. The firm set a “hold” rating on the software maker’s stock.
Veradigm Stock Performance
Shares of Veradigm stock opened at $10.69 on Friday. Veradigm has a 1 year low of $5.01 and a 1 year high of $12.79. The company’s fifty day simple moving average is $9.62 and its 200-day simple moving average is $9.35.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Veradigm stock. Tyro Capital Management LLC purchased a new stake in shares of Veradigm Inc. (NASDAQ:MDRX – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,176,015 shares of the software maker’s stock, valued at approximately $9,055,000. Veradigm accounts for approximately 5.2% of Tyro Capital Management LLC’s portfolio, making the stock its 10th largest holding. Tyro Capital Management LLC owned approximately 1.08% of Veradigm at the end of the most recent quarter.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
- Five stocks we like better than Veradigm
- How to Use the MarketBeat Dividend Calculator
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- ESG Stocks, What Investors Should Know
- Applied Materials Market Capitulates: Now is the Time to Buy
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.